During the past decade, Clinique Saint-Gatien conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Saint-Gatien" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "French Cardiology Society" with 2 trials sponsored, "LivaNova" with 2 trials sponsored and "University Hospital, Rouen" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Saint-Gatien" #1 collaborator was "Agence Régional de Santé du Centre" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Direction Générale de l'Offre de Soins" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator and "France PCI Association" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Saint-Gatien" are "Coronary Artery Disease" (3 trials), "Cardiovascular Diseases" (2 trials), "Coronary Disease" (2 trials), "Coronary Restenosis" (2 trials) and "Angioplasty" (1 trials). Many other conditions were trialed in "Clinique Saint-Gatien" in a lesser frequency.

Most popular intervention types in "Clinique Saint-Gatien" are "Device" (10 trials), "Procedure" (4 trials), "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation by radiofrequency of low-voltage areas" (1 trials), "Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab)" (1 trials), "Atrial flutter ablation" (1 trials), "Atrial flutter ablation and pulmonary vein isolation" (1 trials) and "CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Saint-Gatien" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Saint-Gatien". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Clinique Saint-Gatien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Saint-Gatien, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".